18206-06-9 Usage
General Description
2,6-Dimethylpyridine-4-carboxaldehyde is a chemical compound with the molecular formula C9H9NO. It is a yellow liquid that is primarily used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It is also used as a reagent in the production of high-performance polymers and as a fragrance ingredient in cosmetics and personal care products. The compound has a strong odor and is flammable, requiring careful handling and storage. It is considered to be a potentially hazardous substance and should be used in accordance with safety guidelines and regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 18206-06-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,2,0 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 18206-06:
(7*1)+(6*8)+(5*2)+(4*0)+(3*6)+(2*0)+(1*6)=89
89 % 10 = 9
So 18206-06-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO/c1-6-3-8(5-10)4-7(2)9-6/h3-5H,1-2H3
18206-06-9Relevant articles and documents
Anti-inflammatory agents
-
Page/Page column 139; 140, (2016/02/05)
Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.
